Cut-off values and significance of Oil Red O-positive cells in bronchoalveolar lavage fluid

被引:32
作者
Basset-Leobon, C. [1 ]
Lacoste-Collin, L. [1 ]
Aziza, J. [1 ]
Bes, J. C. [1 ]
Jozan, S. [1 ]
Courtade-Saidi, M. [1 ]
机构
[1] Hop Toulouse Rangueil, Serv Anat Pathol & Histol Cytol, Dept Histol Cytol & Pathol, F-31059 Toulouse 9, France
关键词
bronchoalveolar lavage fluid; alveolar macrophages; Oil red O; cytology; lipid-laden macrophages; PULMONARY ALVEOLAR PROTEINOSIS; FAT-EMBOLISM SYNDROME; IN-VITRO; SURFACTANT; MACROPHAGES; DIAGNOSIS; PNEUMONIA; DISEASE; ASPIRATION;
D O I
10.1111/j.1365-2303.2009.00677.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objective: To evaluate the percentage and predictive value of Oil Red O-positive macrophages (ORO-PM) to identify lipid-laden macrophages in bronchoalveolar lavage fluids (BALF) from patients with different pathologies. Methods: The percentage and absolute numbers of ORO-PM were evaluated in 305 BALF. The patients were separated into ten groups: corticosteroid treatment (n = 18), amiodarone treatment (n = 8), interstitial fibrosis (n = 11), human immunodeficiency virus (HIV)-positive (n = 25), infectious pneumonia (n = 43), severe haematological disorder (n = 25), interstitial syndrome (n = 109), suspicion of cancer (n = 17), transplant recipients (n = 50) and controls (n = 43). The total and differential cell counts in BALF were recorded. The presence of specific pathogens was also noted. Parametric and non-parametric tests were used to compare the values between groups. Receiver-operating characteristics (ROC) curves were established in order to determine a cut-off value. Results: The percentages of ORO-PM were (mean +/- standard deviation) 21.67 +/- 29.12 in the corticosteroid group, 10.00 +/- 12.49 in the amiodarone group, 19.45 +/- 20.72 in the interstitial fibrosis group, 47.80 +/- 30.46 in the HIV group, 19.72 +/- 26.26 in the infectious pneumonia group, 27.42 +/- 30.04 in the severe haematological disorder group, 25.18 +/- 30.63 in the interstitial syndrome group, 17.64 +/- 27.76 in the suspicion of cancer group, 22.50 +/- 27.27 in the transplanted recipients group and 2.63 +/- 3.48 in the control group. Significantly higher values were found in all groups when compared with the control group (P < 0.001). Only the HIV group showed higher numbers of ORO-PM when compared with the interstitial syndrome group (P < 0.01). According to ROC curves, > 6% ORO-PM was suggested as the positive cut-off value. Conclusion: Significantly increased numbers of ORO-PM were associated with various lung pathologies. However, the higher numbers observed in HIV patients require further investigations.
引用
收藏
页码:245 / 250
页数:6
相关论文
共 26 条
  • [1] BAYLISS OB, 1982, THEORY PRACTICE HIST, P217
  • [2] Pseudomonas aeruginosa degrades pulmonary surfactant and increases conversion in vitro
    Beatty, AL
    Malloy, JL
    Wright, JR
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2005, 32 (02) : 128 - 134
  • [3] Bedrossian C W, 1997, Ann Diagn Pathol, V1, P47, DOI 10.1016/S1092-9134(97)80008-1
  • [4] Surfactant proteins in pulmonary alveolar proteinosis in adults
    Brasch, F
    Birzele, J
    Ochs, M
    Guttentag, SH
    Schoch, OD
    Boehler, A
    Beers, MF
    Müller, KM
    Hawgood, S
    Johnen, G
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2004, 24 (03) : 426 - 435
  • [5] Acute pulmonary toxicity in an infant from intravenous amiodarone
    Daniels, CJ
    Schutte, DA
    Hammond, S
    Franklin, WH
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (08) : 1113 - &
  • [6] Diagnosis of Pneumocystis carinii pneumonia in HIV-positive patients -: Bronchoalveolar lavage vs. bronchial brushing
    Djamin, RS
    Drent, M
    Schreurs, AJM
    Groen, EAH
    Wagenaar, SS
    [J]. ACTA CYTOLOGICA, 1998, 42 (04) : 933 - 938
  • [7] DONGAY G, 1985, REV MAL RESPIR, V2, P231
  • [8] Fenneteau O, 2006, ANN BIOL CLIN-PARIS, V64, P17
  • [9] OCCULT PULMONARY HEMORRHAGE IN LEUKEMIA
    GOLDE, DW
    DREW, WL
    KLEIN, HZ
    FINLEY, TN
    CLINE, MJ
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1975, 2 (5964): : 166 - 168
  • [10] Macrophage defences against respiratory tract infections
    Gordon, SB
    Read, RC
    [J]. BRITISH MEDICAL BULLETIN, 2002, 61 : 45 - 61